These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 34788328)

  • 1. Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
    Jiang Y; Duffy F; Hadlock J; Raappana A; Styrchak S; Beck I; Mast FD; Miller LR; Chour W; Houck J; Armistead B; Duvvuri VR; Yeung W; Haglund M; Wallner J; Wallick JA; Hardy S; Oldroyd A; Ko D; Gervassi A; Murray KM; Kaplan H; Aitchison JD; Heath JR; Sather DN; Goldman JD; Frenkel L; Harrington WE
    PLoS One; 2021; 16(11):e0259902. PubMed ID: 34788328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-AT1R autoantibodies and prediction of the severity of Covid-19.
    Papola F; Biancofiore V; Angeletti C; Grimaldi A; Carucci AC; Cofini V; Necozione S; Rosciano A; Marinangeli F; Cervelli C
    Hum Immunol; 2022 Feb; 83(2):130-133. PubMed ID: 34772541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
    Miedema J; Schreurs M; van der Sar-van der Brugge S; Paats M; Baart S; Bakker M; Hoek R; Dik WA; Endeman H; Van Der Velden V; van Gammeren A; Ermens A; Aerts JG; Thüsen JV
    Front Immunol; 2021; 12():684142. PubMed ID: 34054876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
    Jalalonmuhali M; Caroll R; Deayton S; Emery T; Humphreys I; Lim SJ; Lim SK; Coates T
    Hum Immunol; 2020 Dec; 81(12):679-684. PubMed ID: 32736900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
    Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
    Front Immunol; 2021; 12():786039. PubMed ID: 34956217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    Rodriguez-Perez AI; Labandeira CM; Pedrosa MA; Valenzuela R; Suarez-Quintanilla JA; Cortes-Ayaso M; Mayán-Conesa P; Labandeira-Garcia JL
    J Autoimmun; 2021 Aug; 122():102683. PubMed ID: 34144328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
    Sorohan BM; Ismail G; Berechet A; Obrișcă B; Constantinescu I; Mărunțelu I; Tacu D; Baston C; Sinescu I
    Transpl Immunol; 2021 Jun; 66():101389. PubMed ID: 33838295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
    Williams TA; Jaquin D; Burrello J; Philippe A; Yang Y; Rank P; Nirschl N; Sturm L; Hübener C; Dragun D; Bidlingmaier M; Beuschlein F; Reincke M
    Hypertension; 2019 Oct; 74(4):784-792. PubMed ID: 31476909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele С (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population.
    Izmailova O; Shlykova O; Vatsenko A; Ivashchenko D; Dudchenko M; Koval T; Kaidashev I
    Infect Genet Evol; 2022 Mar; 98():105227. PubMed ID: 35091110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients.
    Viboon S; Townamchai N; Phiancharoen S; Kupatawintu P; Dhitivat V; Nathalang O
    Transplant Proc; 2018 Jun; 50(5):1310-1315. PubMed ID: 29880351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II Type 1 Receptor Expression in Renal Transplant Biopsies and Anti-AT1R Antibodies in Serum Indicates the Risk of Transplant Loss.
    Sas-Strózik A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Gawlik K; Mazanowska O; Madziarska K; Hałoń A; Krajewska M; Banasik M
    Transplant Proc; 2020 Oct; 52(8):2299-2304. PubMed ID: 32448653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC; Bagnasco S; Kraus ES; Montgomery RA; Dragun D; Leffell MS; Zachary AA; Jackson AM
    Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiotensin II type 1 receptor autoantibodies (AT
    İlgen U; Yayla ME; Düzgün N
    Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
    Son BS; Lee HJ; Cho WH; So MW; Park JM; Yeo HJ
    Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of ACE2 autoantibodies after SARS-CoV-2 infection.
    Arthur JM; Forrest JC; Boehme KW; Kennedy JL; Owens S; Herzog C; Liu J; Harville TO
    PLoS One; 2021; 16(9):e0257016. PubMed ID: 34478478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
    Cabral-Marques O; Halpert G; Schimke LF; Ostrinski Y; Vojdani A; Baiocchi GC; Freire PP; Filgueiras IS; Zyskind I; Lattin MT; Tran F; Schreiber S; Marques AHC; Plaça DR; Fonseca DLM; Humrich JY; Müller A; Giil LM; Graßhoff H; Schumann A; Hackel A; Junker J; Meyer C; Ochs HD; Lavi YB; Scheibenbogen C; Dechend R; Jurisica I; Schulze-Forster K; Silverberg JI; Amital H; Zimmerman J; Heidecke H; Rosenberg AZ; Riemekasten G; Shoenfeld Y
    Nat Commun; 2022 Mar; 13(1):1220. PubMed ID: 35264564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients.
    Miedema JR; Janssen ML; von der Thüsen J; Endeman H; Langerak AW; Hellemons ME; van Nood E; Peeters BWA; Baart SJ; Schreurs MWJ
    Front Immunol; 2023; 14():1204433. PubMed ID: 37622126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
    Giral M; Foucher Y; Dufay A; Duong Van Huyen JP; Renaudin K; Moreau A; Philippe A; Hegner B; Dechend R; Heidecke H; Brouard S; Cesbron A; Castagnet S; Devys A; Soulillou JP; Dragun D
    Am J Transplant; 2013 Oct; 13(10):2567-76. PubMed ID: 23919486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
    Pizzo H; Mirocha J; Choi J; Garrison J; Haas M; Zhang X; Kamil ES; Kim I; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Dec; 26(8):e14400. PubMed ID: 36168673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.